Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 09-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1,345 | 3 | 0 | 0 |
| Other current assets | 0 | 168 | 0 | 0 |
| TOTAL | $1,745 | $171 | $0 | $0 |
| Non-Current Assets | ||||
| Investments And Advances | 143,753 | 0 | 0 | 0 |
| TOTAL | $143,753 | $N/A | $N/A | $N/A |
| Total Assets | $145,499 | $171 | $0 | $0 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 650 | 0 | 0 | 0 |
| Accrued Expenses | 324 | 67 | 0 | 0 |
| TOTAL | $974 | $147 | $0 | $0 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 139,525 | 0 | 0 | 0 |
| TOTAL | $139,525 | $N/A | $N/A | $N/A |
| Total Liabilities | $140,499 | $147 | $0 | $0 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 18,456 | 18,456 | N/A | N/A |
| Common Shares | 1 | 0 | 0 | 0 |
| Retained earnings | -735 | -1 | 0 | 0 |
| TOTAL | $5,000 | $24 | $0 | $0 |
| Total Liabilities And Equity | $145,499 | $171 | $0 | $0 |